Inactive Instrument

News PCAS

Stocks

PCA

FR0000053514

Pharmaceuticals

All News

09/24/09	Orapi: takeover bid reopens on February 12
02/24/02	Orapi: 3.15 million shares tendered to the takeover bid
22/23/22	Orapi: takeover bid opens on December 27
18/23/18	PCAS: 200 ME capital increase
03/23/03	PCAS: OPAS to start this Friday
24/23/24	PCAS: Net Sales as of September 30, 2023	GL
24/23/24	PCAS Announces the Consolidated Net Sales Results for the Month of September 30, 2023	CI
07/23/07	PCAS: Seqens launches minority share offer
06/23/06	PCAS: RESULTS AS OF JUNE 30, 2023	GL
06/23/06	PCAS SA Reports Earnings Results for the Half Year Ended June 30, 2023	CI
27/23/27	PCAS SA Reports Consolidated Sales Results for the Period Ended June 30, 2023	CI
27/23/27	Pcas: Net sales as of June 30, 2023	GL
25/23/25	PCAS: sale of Canadian subsidiary confirmed
25/23/25	PCAS to Divest Canadian Arm to Japan's DIC	MT
25/23/25	PCAS to sell its Canadian subsidiary, PCAS Canada Inc., to DIC Corporation	GL
03/23/03	PCAS: buoyed by offer for Canadian subsidiary
03/23/03	France's PCAS Enters Exclusive Talks for Canadian Unit Sale to Japan's DIC	MT
02/23/02	PCAS enters into exclusive negotiations with DIC Corporation following receipt of an offer for the acquisition of its Canadian subsidiary, PCAS Canada Inc.	GL
28/23/28	PCAS: RELEASE OF THE 2022 UNIVERSAL REGISTRATION DOCUMENT (URD)	GL
24/23/24	Pcas: NET SALES AS OF MARCH 31, 2023	GL
31/23/31	PCAS: larger net loss in 2022
30/23/30	Pcas: 2022 annual results	GL
30/23/30	Pcas: 2022 annual results	GL
30/23/30	PCAS SA Reports Earnings Results for the Full Year Ended December 31, 2022	CI
07/23/07	PCAS: 21% increase in sales by 2022

No results match your criteria

All News Broker Recommendations Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

News PCAS

Stocks

PCA

FR0000053514

Pharmaceuticals

All News

Filters